These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways. Chen C, Li L, Liu X, Zhang D, Liu Y, Li Y. J Ethnopharmacol; 2023 Jan 10; 300():115725. PubMed ID: 36115602 [Abstract] [Full Text] [Related]
12. Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways. Yan LS, Cui S, Cheng BC, Yin XB, Wang YW, Qiu XY, Nima CR, Zhang Y, Zhang SF. Drug Des Devel Ther; 2023 Jan 10; 17():297-312. PubMed ID: 36756190 [Abstract] [Full Text] [Related]
13. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway. Zhu Y, Han Q, Wang L, Wang B, Chen J, Cai B, Wu C, Zhu X, Liu F, Han D, Dong H, Jia Y, Liu Y. J Ethnopharmacol; 2023 Jan 30; 301():115763. PubMed ID: 36183949 [Abstract] [Full Text] [Related]
19. Sevoflurane inhibits nuclear factor-κB activation in lipopolysaccharide-induced acute inflammatory lung injury via toll-like receptor 4 signaling. Sun XJ, Li XQ, Wang XL, Tan WF, Wang JK. PLoS One; 2015 Nov 30; 10(4):e0122752. PubMed ID: 25875290 [Abstract] [Full Text] [Related]
20. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway. Wu X, Lin L, Wu H. J Biochem Mol Toxicol; 2021 Mar 30; 35(3):e22664. PubMed ID: 33140555 [Abstract] [Full Text] [Related] Page: [Next] [New Search]